Human gene therapy - JoVE Visualize

Showing results (211-220 of 4,122) with videos related to

Pageof 413

Sort By:

Human Gene Therapy|November 14, 1997

Selective immunoaffinity-based enrichment of CD34+ cells transduced with retroviral vectors containing an intracytoplasmatically truncated version of the human low-affinity nerve growth factor receptor (deltaLNGFR) geneB Fehse, A Uhde, N Fehse, et al.

Human Gene Therapy|November 14, 1997

Bystander effects of different enzyme-prodrug systems for cancer gene therapy depend on different pathways for intercellular transfer of toxic metabolites, a factor that will govern clinical choice of appropriate regimesC Denning, J D Pitts

Human Gene Therapy|February 24, 1998

Improvement of retroviral packaging cell lines by introducing the polyomavirus early regionT Yoshimatsu, M Tamura, S Kuriyama, et al.

Human Gene Therapy|February 24, 1998

Induction of cytotoxic oxidative stress by D-alanine in brain tumor cells expressing Rhodotorula gracilis D-amino acid oxidase: a cancer gene therapy strategyL D Stegman, H Zheng, E R Neal, et al.

Human Gene Therapy|February 24, 1998

The immune response elicited by mammary adenocarcinoma cells transduced with interferon-gamma and cytosine deaminase genes cures lung metastases by parental cellsP Nanni, C De Giovanni, G Nicoletti, et al.

Human Gene Therapy|October 10, 1997

Cell-surface marking of CD(34+)-restricted phenotypes of human hematopoietic progenitor cells by retrovirus-mediated gene transferL Ruggieri, A Aiuti, M Salomoni, et al.

Human Gene Therapy|December 31, 1997

Promoter attenuation in gene therapy: interferon-gamma and tumor necrosis factor-alpha inhibit transgene expressionL Qin, Y Ding, D R Pahud, et al.

Human Gene Therapy|December 31, 1997

Therapeutic efficiency and safety of a second-generation replication-conditional HSV1 vector for brain tumor gene therapyC M Kramm, M Chase, U Herrlinger, et al.

Human Gene Therapy|December 31, 1997

Comparison of the protection of cells from antifolates by transduced human dihydrofolate reductase mutantsM Patel, S E Sleep, W S Lewis, et al.

Human Gene Therapy|December 31, 1997

Efficient gene transfer in primitive CD34+/CD38lo human bone marrow cells reselected after long-term exposure to GALV-pseudotyped retroviral vectorH Glimm, H P Kiem, B Darovsky, et al.

Pageof 413

Showing results (211-220 of 4,122) with videos related to

Sort By:

Pageof 413

Human Gene Therapy|November 14, 1997

Selective immunoaffinity-based enrichment of CD34+ cells transduced with retroviral vectors containing an intracytoplasmatically truncated version of the human low-affinity nerve growth factor receptor (deltaLNGFR) geneB Fehse, A Uhde, N Fehse, et al.

Human Gene Therapy|November 14, 1997

Bystander effects of different enzyme-prodrug systems for cancer gene therapy depend on different pathways for intercellular transfer of toxic metabolites, a factor that will govern clinical choice of appropriate regimesC Denning, J D Pitts

Human Gene Therapy|February 24, 1998

Improvement of retroviral packaging cell lines by introducing the polyomavirus early regionT Yoshimatsu, M Tamura, S Kuriyama, et al.

Human Gene Therapy|February 24, 1998

Induction of cytotoxic oxidative stress by D-alanine in brain tumor cells expressing Rhodotorula gracilis D-amino acid oxidase: a cancer gene therapy strategyL D Stegman, H Zheng, E R Neal, et al.

Human Gene Therapy|February 24, 1998

The immune response elicited by mammary adenocarcinoma cells transduced with interferon-gamma and cytosine deaminase genes cures lung metastases by parental cellsP Nanni, C De Giovanni, G Nicoletti, et al.

Human Gene Therapy|October 10, 1997

Cell-surface marking of CD(34+)-restricted phenotypes of human hematopoietic progenitor cells by retrovirus-mediated gene transferL Ruggieri, A Aiuti, M Salomoni, et al.

Human Gene Therapy|December 31, 1997

Promoter attenuation in gene therapy: interferon-gamma and tumor necrosis factor-alpha inhibit transgene expressionL Qin, Y Ding, D R Pahud, et al.

Human Gene Therapy|December 31, 1997

Therapeutic efficiency and safety of a second-generation replication-conditional HSV1 vector for brain tumor gene therapyC M Kramm, M Chase, U Herrlinger, et al.

Human Gene Therapy|December 31, 1997

Comparison of the protection of cells from antifolates by transduced human dihydrofolate reductase mutantsM Patel, S E Sleep, W S Lewis, et al.

Human Gene Therapy|December 31, 1997

Efficient gene transfer in primitive CD34+/CD38lo human bone marrow cells reselected after long-term exposure to GALV-pseudotyped retroviral vectorH Glimm, H P Kiem, B Darovsky, et al.

Pageof 413